Tag Archives: Biotechnology

Millionaire’s gift to San Diego

homecoverBusinessman and philanthropist T. Denny Sanford committed $100 million this November to create a stem cell center at the University of California in San Diego (UCSD). The Sanford Stem Cell Clinical Center will be directed by Lawrence Goldstein, who already directs UCSD’s stem cell research and the existing Sanford Consortium for Regenerative Medicine. “The goal is very straightforward,” Goldstein says, “and that is to accelerate the development of stem cell–based therapies for patients with intractable diseases.” Continue reading Millionaire’s gift to San Diego

Greenpeace campaign prompts Philippine ban on Bt eggplant trials

homecoverA court in the Philippines has ordered scientists to halt field trials of Bacillus thuringiensis (Bt) eggplant, over concerns that the genetically modified (GM) crop poses a risk to human health and the environment. On May 17, 2013, the Philippine Court of Appeals issued a cease-and-desist order to scientists running the field trials, a ruling that, if upheld, could set a precedent that may affect other biotech crops in development locally, such as the Golden Rice and GM papaya and abaca under development in the country. Continue reading Greenpeace campaign prompts Philippine ban on Bt eggplant trials

Argentina cuts GM red tape

homecoverArgentina has streamlined its biotech crop regulatory framework to ensure neither red tape nor international trading partners’ policies hold up commercialization. The country, one of the first to embrace biotech crops, relied for two decades on a hodgepodge of agencies and rules to govern genetically modified (GM) crop commercialization (Nat. Biotechnol. 28, 393–395, 2010). A 2010 reform established a new Ministry for Agriculture, Livestock and Fisheries, which updated and consolidated rules in 2012. This spring, the Ministry packaged those rules in a single booklet for commercial and academic growers. Continue reading Argentina cuts GM red tape